Biovia translates Roadmaps into four COOCK+ project proposals and is inviting members to join
Let’s make it happen!
After introducing the brand-new Biovia Roadmaps, we want to strike while the iron's hot. That's why we're taking concrete action by applying for COOCK+ funding through VLAIO by the end of the year. COOCK+ projects are designed to help Flemish companies innovate faster by developing practical, openly available knowledge and tools that address shared industry challenges.
Join the Advisory Board of a COOCK+ proposal
Strong collaborative projects start with industry input. That's why we're inviting companies to join the Advisory Boards of our COOCK+ project proposals. As these are currently project proposals (funding has not yet been awarded), advisory board members will first be consulted before submission and have the opportunity to help shape the project so it addresses the most relevant industry challenges. If funded, the advisory board will act as a sounding board throughout the project, providing strategic feedback, ensuring the project remains aligned with the needs of the target companies and helping maximise the practical implementation and impact of the project results.
“The Roadmaps provide a common direction for our ecosystem and show where collaboration can make a difference. These first projects are an opportunity to jointly develop and share knowledge that strengthens innovation across the sector.”
Kim Luyckx, Innovation Director at Biovia
Get to know the proposals
MARA

MARA is a COOCK+ project proposal that aims to help medtech and digital health companies make better market access decisions from the earliest stages of product development. The project will develop practical, open tools and an Early HTA methodology that connect clinical need, evidence generation, health economics, reimbursement, procurement, adoption and investment readiness. By integrating these decisions earlier, MARA will support companies in reducing development risk and accelerating successful market access, in line with the Biovia Market Acceleration Roadmap.
We are looking for medtech and digital health companies, from start-ups and scale-ups to established SMEs, that are developing innovative healthcare solutions and are willing to share their market access challenges, provide feedback on the methodology and help ensure the project delivers practical value for the broader ecosystem.
Interested in joining? Contact Rita Prota and Tessa Johnson to start the conversation.
VALUE-READY HealthTech

VALUE-READY HealthTech is a COOCK+ project proposal that aims to help digital health companies become better prepared for hospital validation and implementation by putting value generation and demonstration at the center of product development. The project will develop practical, open tools that help companies define the hospital need they address, build a strong value proposition, and translate this into realistic evidence, workflow and implementation plans. In doing so, it supports the principles of the Biovia Value-Based Healthcare Roadmap, helping companies develop solutions that are better aligned with outcome-driven healthcare and more likely to achieve successful adoption.
We are looking for digital health companies, from start-ups and scale-ups to established SMEs, that develop solutions requiring hospital validation or implementation and are willing to share their challenges, provide feedback on the methodology and help ensure the project delivers practical value for the broader ecosystem.
Interested in joining? Contact Liz Renzaglia to start the conversation.
CTRL-IT

CTRL-IT (Clinical Trial Readiness & Innovation Track) is a COOCK+ project proposal that aims to help biotech, medtech, diagnostics and digital health companies better prepare for clinical trials. The project will develop a practical, provider-neutral readiness framework that helps companies assess where they stand, identify gaps across clinical evidence, regulatory, quality, operational and funding readiness, and determine the right next steps. By providing earlier clarity and connecting companies to the right expertise and support, CTRL-IT will help SMEs reduce avoidable setbacks and move towards clinical studies with greater confidence, in line with the Biovia Clinical Trials Roadmap.
We are looking for biotech, medtech, diagnostics and digital health companies, from start-ups and scale-ups to established SMEs, that are preparing for or considering a clinical trial and are willing to share their challenges, provide feedback on the framework and help ensure the project delivers practical value for the broader ecosystem. We also welcome other clinical trial stakeholders, including R&D enablers and hospitals, to join the advisory board.
Interested in joining? Contact Katrien Lorré to start the conversation.
HURRAY
HURRAY (Human-Relevant Translational Evidence Readiness Platform) is a COOCK+ project proposal that aims to help biotech, medtech and digital health companies make better decisions on the use of human-relevant non-animal models (NAMs) during product development. The project will develop a practical, provider-neutral decision guide that helps companies assess whether a specific model and its supporting evidence are fit for purpose, identify remaining evidence gaps, and determine appropriate next steps. In doing so, it supports the principles of the TechBio & Translational Innovation Roadmap by accelerating the adoption of human-relevant technologies and strengthening translational decision-making across the Flemish life sciences ecosystem.
We are looking for a balanced advisory board, with a strong representation of biotech, medtech and digital health companies that use or are considering human-relevant non-animal models in their R&D. We also welcome NAM technology providers, CROs, QA/RA and evidence-generation specialists, AI/data partners and clinical end-users to ensure the methodology reflects the needs and perspectives of the entire translational innovation ecosystem.
Interested in joining? Contact Ann Van Gysel to start the conversation.
Already registered for a Roadmap Working Group? If you're eligible to join one of the Advisory Boards, we'll contact you directly.